OBJECTIVE: To explore myelin components and mitochondrial changes within the central nervous system in patients with well-characterized mitochondrial disorders due to nuclear DNA or mitochondrial DNA (mtDNA) mutations. DESIGN: Immunohistochemical analysis, histochemical analysis, mtDNA sequencing, and real-time and long-range polymerase chain reaction were used to determine the pathogenicity of mtDNA deletions. SETTING: Department of Clinical Pathology, Columbia University Medical Center, and Newcastle Brain Tissue Resource. PATIENTS: Seventeen patients with mitochondrial disorders and 7 controls were studied from August 1, 2009, to August 1, 2010. MAIN OUTCOME MEASURE: Regions of myelin-associated glycoprotein (MAG) loss. RESULTS: Myelin-associated glycoprotein loss in Kearns-Sayre syndrome was associated with oligodendrocyte loss and nuclear translocation of apoptosis-inducing factor, whereas inflammation, neuronal loss, and axonal injury were minimal. In a Kearns-Sayre syndrome MAG loss region, high levels of mtDNA deletions together with cytochrome- c oxidase-deficient cells and loss of mitochondrial respiratory chain subunits (more prominent in the white than gray matter and glia than axons) confirmed the pathogenicity of mtDNA deletions. CONCLUSION: Primary mitochondrial respiratory chain defects affecting the white matter, and unrelated to inflammation, are associated with MAG loss and central nervous system demyelination.
OBJECTIVE: To explore myelin components and mitochondrial changes within the central nervous system in patients with well-characterized mitochondrial disorders due to nuclear DNA or mitochondrial DNA (mtDNA) mutations. DESIGN: Immunohistochemical analysis, histochemical analysis, mtDNA sequencing, and real-time and long-range polymerase chain reaction were used to determine the pathogenicity of mtDNA deletions. SETTING: Department of Clinical Pathology, Columbia University Medical Center, and Newcastle Brain Tissue Resource. PATIENTS: Seventeen patients with mitochondrial disorders and 7 controls were studied from August 1, 2009, to August 1, 2010. MAIN OUTCOME MEASURE: Regions of myelin-associated glycoprotein (MAG) loss. RESULTS: Myelin-associated glycoprotein loss in Kearns-Sayre syndrome was associated with oligodendrocyte loss and nuclear translocation of apoptosis-inducing factor, whereas inflammation, neuronal loss, and axonal injury were minimal. In a Kearns-Sayre syndrome MAG loss region, high levels of mtDNA deletions together with cytochrome- c oxidase-deficient cells and loss of mitochondrial respiratory chain subunits (more prominent in the white than gray matter and glia than axons) confirmed the pathogenicity of mtDNA deletions. CONCLUSION: Primary mitochondrial respiratory chain defects affecting the white matter, and unrelated to inflammation, are associated with MAG loss and central nervous system demyelination.
Authors: E Jaros; D J Mahad; G Hudson; D Birchall; S J Sawcer; P G Griffiths; J Sunter; D A S Compston; R H Perry; P F Chinnery Journal: Neurology Date: 2007-07-10 Impact factor: 9.910
Authors: C T Moraes; S DiMauro; M Zeviani; A Lombes; S Shanske; A F Miranda; H Nakase; E Bonilla; L C Werneck; S Servidei Journal: N Engl J Med Date: 1989-05-18 Impact factor: 91.245
Authors: Sarah E Lutz; Yongmei Zhao; Maria Gulinello; Sunhee C Lee; Cedric S Raine; Celia F Brosnan Journal: J Neurosci Date: 2009-06-17 Impact factor: 6.167
Authors: H E Gendelman; G H Pezeshkpour; N J Pressman; J S Wolinsky; R H Quarles; M J Dobersen; B D Trapp; C A Kitt; A Aksamit; R T Johnson Journal: Ann Neurol Date: 1985-09 Impact factor: 10.422
Authors: Andreas Bender; Kim J Krishnan; Christopher M Morris; Geoffrey A Taylor; Amy K Reeve; Robert H Perry; Evelyn Jaros; Joshua S Hersheson; Joanne Betts; Thomas Klopstock; Robert W Taylor; Douglass M Turnbull Journal: Nat Genet Date: 2006-04-09 Impact factor: 38.330
Authors: Barbara Maria Krauspe; Wolfgang Dreher; Cordian Beyer; Werner Baumgartner; Bernd Denecke; Katharina Janssen; Claus-Dieter Langhans; Tim Clarner; Markus Kipp Journal: J Mol Neurosci Date: 2014-09-05 Impact factor: 3.444
Authors: Maria Camilla Rossi-Espagnet; Martina Lucignani; Luca Pasquini; Antonio Napolitano; Stefano Pro; Andrea Romano; Daria Diodato; Diego Martinelli; Daniela Longo Journal: Neuroradiology Date: 2019-11-04 Impact factor: 2.804
Authors: Felix Chan; Nichola Z Lax; Caroline Marie Voss; Blanca Irene Aldana; Shuna Whyte; Alistair Jenkins; Claire Nicholson; Sophie Nichols; Elizabeth Tilley; Zoe Powell; Helle S Waagepetersen; Ceri H Davies; Doug M Turnbull; Mark O Cunningham Journal: Brain Date: 2019-02-01 Impact factor: 13.501
Authors: Jelle van den Ameele; Young Hong; Roido Manavaki; Antonina Kouli; Heather Biggs; Zoe MacIntyre; Rita Horvath; Patrick Yu-Wai-Man; Evan Reid; Caroline H Williams-Gray; Ed Bullmore; Franklin Aigbirhio; Tim Fryer; Patrick Chinnery Journal: Neurology Date: 2021-04-21 Impact factor: 9.910
Authors: Nichola Z Lax; John Grady; Alex Laude; Felix Chan; Philippa D Hepplewhite; Grainne Gorman; Roger G Whittaker; Yi Ng; Mark O Cunningham; Doug M Turnbull Journal: Neuropathol Appl Neurobiol Date: 2015-05-30 Impact factor: 8.090
Authors: Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale Journal: Oxid Med Cell Longev Date: 2014-05-04 Impact factor: 6.543